Giant cell arteritis: early diagnosis is key
Open Access
- 1 January 2019
- journal article
- review article
- Published by Taylor & Francis Ltd in Eye and Brain
- Vol. ume 11, 1-12
- https://doi.org/10.2147/eb.s170388
Abstract
Giant cell arteritis (GCA) is an inflammatory vasculitis typically affecting elderly that can potentially cause vision loss. Studies have demonstrated that early recognition and initiation of treatment can improve visual prognosis in patients with GCA. This review addresses the benefits of early diagnosis and treatment, and discusses the available treatment options to manage the disease.Keywords
This publication has 53 references indexed in Scilit:
- Biologic agents in systemic vasculitisInternational Journal of Clinical Rheumatology, 2011
- Giant Cell Arteritis: Laboratory Predictors of a Positive Temporal Artery BiopsyOphthalmology, 2011
- Giant cell arteritis: an updated reviewActa Ophthalmologica, 2009
- Interleukin‐6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responsesArthritis & Rheumatism, 2008
- A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effectsAnnals Of The Rheumatic Diseases, 2007
- Adjunctive methotrexate for treatment of giant cell arteritis: An individual patient data meta‐analysisArthritis & Rheumatism, 2007
- Giant Cell ArteritisCardiology in Review, 2007
- Early menopause, low body mass index, and smoking are independent risk factors for developing giant cell arteritisAnnals Of The Rheumatic Diseases, 2006
- Giant Cell ArteritisMedicine, 2005
- Steroid management in giant cell arteritisBritish Journal of Ophthalmology, 2001